Loading claim details...
Loading claim details...
BioXcel Therapeutics
Investors who bought BioXcel Therapeutics stock between March 9 and June 28, 2023, may be eligible to claim a cash payment from a class action settlement.
Class members are U.S. investors who purchased BioXcel Therapeutics stock between March 9 and June 28, 2023.
States: US
Estimated $1.10 per share
Proof required
Claim deadline
Final date to submit a claim
First listed by ClaimCat: June 3, 2026
Source: claimdepot
Last structured update: June 11, 2026
Structured from existing ClaimsCat claim fields. Review the official settlement website before filing.
ClaimCat is not the claims administrator, a law firm, or a government agency. We link to official settlement websites so you can review details and file directly with the administrator.